Our genetics and functional data suggest that compound heterozygous ATP10B mutations contribute to risk for PD and DLB by a loss-of-function mechanism resulting in a dysregulated GluCer and PC homeostasis and lysosomal dysfunction. The gene discussed is ATP10B; the disease is Lewy body dementia.